RecruitingNot ApplicableNCT06598319

Evaluation of Pulsed Field Ablation of the Posterior Nasal Nerve for Chronic Rhinitis


Sponsor

Aventix Medical Inc.

Enrollment

30 participants

Start Date

Nov 15, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Evaluation of safety, effectiveness and tolerability of the Aventix Medical Device used for the treatment of chronic rhinitis


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria5

  • The subject is 18 to 85 years of age.
  • The subject has had symptoms of chronic rhinitis for greater than 6 months with insufficient response to nasal steroids.
  • The subject has an rTNSS total score of ≥ 6.
  • The subject has had moderate to severe symptoms of rhinorrhea and/or nasal congestion (rTNSS rating of 2 or 3 for rhinorrhea and 1, 2, or 3 for congestion)
  • The subject is able and willing to provide written informed consent and comply with the protocol requirements.

Exclusion Criteria16

  • The subject has clinically significant anatomic obstructions on either side that limit access to the posterior nose, including severe septal deviation, nasal polyps, and sinonasal tumor
  • The subject has a septal perforation
  • The subject has had prior sinus or nasal surgery on either side that significantly alters the anatomy of the posterior nose.
  • The subject had had previous surgery of the PNN for chronic rhinitis.
  • The subject has had prior head or neck irradiation
  • The subject has an active or chronic nasal or sinus infection
  • The subject has active coagulation disorder, or the patient is receiving anticoagulants
  • The subject has a history of dry eye or dry nose symptoms
  • Patient has rhinitis medicamentosa
  • The subject has ocular allergic symptoms
  • The subject has a history of nose bleeds
  • The subject has electrically sensitive implants (e.g. cochlear implants, pacemakers, defibrillators)
  • The subject is pregnant or lactating
  • The subject is participating in another clinical research study
  • The subject has an allergy or intolerance to anesthetic agent
  • Any physical condition that, in the Investigator's opinion, would prevent adequate study participation or pose an increased risk

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENOVOCLEAR™ Device

Pulsed field energy applied to soft tissues in the nasal airway, including the posterior nasal nerve distribution.


Locations(3)

Colorado ENT and Allergy

Colorado Springs, Colorado, United States

Bay Area ENT

Ocean Springs, Mississippi, United States

Atkins Expert Sinus Care

San Antonio, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06598319


Related Trials